Prakiraan wutah bathi resik saben saham kanggo taun ngarep MiNK Therapeutics (INKT)

Simbol lan logo merek MiNK (INKT)

The scalability of MiNK Therapeutics, Inc. (INKT) cell platforms enables the mass delivery of affordable therapies. The current consensus EPS growth forecast for next year reflects expectations fixed at 32.60. Strong pricing power in the solid tumor segment and patent protection of iNKT technologies create a robust barrier to entry for competitors, ensuring the company's long-term dominance in immuno-oncology.

INKT - Prakiraan wutah bathi kanggo taun ngarep MiNK ing rentang 04.07.2022 - 18.11.2026

Rincian metrik lan analitis perusahaan MiNK (INKT)

- rega lan prakiraan konsensus rega:
Analisis kabeh metrik perusahaan:MiNK
Barang utama MiNK Therapeutics Inc.

When screening issuer reliability, this indicator allows for an assessment of the consensus forecast for future profitability through the dynamics of expected earnings per share. The metric measures the rate of change in net income, determining fair pricing multiples and business value equilibrium points. For MiNK Therapeutics, Inc. (INKT), with its patent potential in cancer therapy, the earnings growth rate model for the coming year reflects market confidence in the commercialization of its innovations.

Pesaing langsung

Prakiraan wutah bathi resik saben saham kanggo taun ngarep immunitybio.com|Prakiraan wutah bathi saben saham kanggo taun ngarep immunocore.com (IMCR)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Janux Therapeutics Inc (JANX)|Prakiraan wutah bathi saben saham kanggo taun ngarep Arcus Bio RCUS|Zymeworks Inc - Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep Tango Therapeutics Corp TNGX|IOVA - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|IMTX (immatics.com) - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|Xencor Inc. (XNCR) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Compass Bio (CMPX)|Prakiraan wutah bathi saben saham kanggo taun ngarep REPL|LYEL - Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep IPHA (Innate Pharma, S.A.)|Proyeksi tambahing bathi saben saham ing taun ngarep PYXS|Prakiraan wutah bathi kanggo taun ngarep CGEN (Compugen Ltd.)|Dinamika bathi saben saham sing diarepake ing taun ngarep IOBT|sutrobio.com - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Werewolf Therapeutics, Inc.|Immix (IMMX) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|ALX Oncology Holdings - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Cue Biopharma|Prakiraan wutah bathi kanggo taun ngarep pdsbiotech.com|Prakiraan wutah bathi resik saben saham kanggo taun ngarep sonnetbio.com (SONN)|MAIA: Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep|Liminatus Pharma Inc. - Prakiraan wutah bathi saben saham kanggo taun ngarep|LAVA Therapeutics N.V. (LVTX) - Prakiraan wutah bathi resik saben saham ing taun ngarep|NXTC - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|LPTX: Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Intensity Therapeutics (INTS) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Sensei Bio (SNSE)|TOVX (Theriva Biologics Inc) - Prakiraan wutah bathi kanggo taun ngarep|Gritstone bio (GRTS) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep KA|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep NexImmune Inc|Prakiraan wutah bathi resik saben saham kanggo taun ngarep turnstonebio.com TSBX|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Vaccinex Inc (VCNX)|HARP - Prakiraan wutah bathi resik saben saham kanggo taun ngarep